Major ENvue Medical (FEED) holder sells 210K shares, stake at 0%

Rhea-AI Filing Summary

ENvue Medical, Inc. disclosed that shareholder Christian Michael Glibert has fully exited his position in the company’s common stock. On June 22, 2026, he sold his remaining 210,000 shares in open market trades at a weighted average price of $0.6880 per share, with prices ranging from $0.6756 to $0.7220. Following these sales, he beneficially owns 0 shares, representing 0.0% of ENvue’s outstanding common stock, and reports no contracts or arrangements related to the company’s securities.

Insights

Equity ownership and governance analyst

A former >5% ENvue holder has sold out entirely.

The filing shows that Christian Michael Glibert, previously a significant shareholder of ENvue Medical, Inc., disposed of his remaining 210,000 shares in open market transactions on June 22, 2026. The weighted average sale price was $0.6880 per share, with trades between $0.6756 and $0.7220.

After these transactions, he reports beneficial ownership of 0 shares, or 0.0% of the company’s common stock, and states he has no related plans or arrangements affecting corporate control. The filing also notes that he ceased to be a beneficial owner of more than 5.0% of the stock as of June 22, 2026.

This change reflects a complete exit by one reporting holder. The practical impact on ENvue depends on how other shareholders and the market respond, which is not detailed here; the document focuses solely on recording the ownership change.

Key Figures

Shares sold: 210,000 shares Weighted average sale price: $0.6880 per share Sale price range: $0.6756–$0.7220 per share +3 more

6 metrics

Shares sold 210,000 shares Common stock disposed on June 22, 2026

Weighted average sale price $0.6880 per share Open market transactions on June 22, 2026

Sale price range $0.6756–$0.7220 per share Prices of multiple tranches sold June 22, 2026

Post-transaction holdings 0 shares Beneficial ownership as of June 22, 2026

Ownership percentage 0.0% of class Common stock beneficial ownership after disposition

Former reporting threshold More than 5.0% Ceased to be beneficial owner of >5.0% on June 22, 2026

Key Terms

beneficially owns, open market transactions, weighted average price, ceased to be the beneficial owner, +1 more

5 terms

beneficially owns financial

"As of June 22, 2026, the Reporting Person beneficially owns 0 shares of Common Stock"

Beneficially owns means a person or entity enjoys the economic benefits and control of a security even if the legal title or registration is held in another name. Think of it like having the keys and profits from a car that is registered to a friend: you use it, benefit from it, and make decisions about it even though the official paperwork lists someone else. For investors, this matters because it reveals who truly controls shares, affects voting power, potential conflicts of interest, and regulatory disclosure obligations.

open market transactions financial

"disposed of an aggregate of 210,000 shares of Common Stock in open market transactions"

Open market transactions are the buying and selling of a company’s shares or other securities conducted on public exchanges or through the wider market rather than through private deals or negotiated placements. They matter to investors because these trades change supply and demand in real time—like shoppers affecting a store’s inventory—and so can move prices, signal management or investor sentiment, affect liquidity, and alter ownership stakes that influence future returns and risk.

weighted average price financial

"at a weighted average price of $0.6880 per share"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

ceased to be the beneficial owner financial

"On June 22, 2026, the Reporting Person ceased to be the beneficial owner of more than 5.0%"

Schedule 13D financial

"previously filed a statement on Schedule 13G to report the acquisition"

A Schedule 13D is a legal document that investors file with regulators when they buy a large enough stake in a company to potentially influence its management or decisions. It provides details about the investor’s intention, ownership stake, and plans, helping other investors understand who is gaining control and what their motives might be.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 06/22/2026 - 02:10 PM Accepted by SEC EDGAR 06/22/2026 - 02:10 PM Learn about SEC filing dates

FAQ

What does the ENvue Medical (FEED) Schedule 13D/A report about Christian Michael Glibert?

It reports that Christian Michael Glibert has fully exited his ENvue Medical common stock position. As of June 22, 2026, he beneficially owns 0 shares, representing 0.0% of the outstanding common stock, and has no related control or transaction plans.

How many ENvue Medical shares did Christian Michael Glibert sell on June 22, 2026?

He sold an aggregate of 210,000 ENvue Medical common shares on June 22, 2026. The trades were executed in multiple open market tranches, with prices ranging from $0.6756 to $0.7220 per share according to the filing.

At what price did Christian Michael Glibert sell his ENvue Medical (FEED) shares?

His ENvue Medical shares were sold at a weighted average price of $0.6880 per share. The filing notes that individual trades occurred between $0.6756 and $0.7220 per share in open market transactions on June 22, 2026.

What is Christian Michael Glibert’s current ownership percentage in ENvue Medical?

After the reported transactions, Christian Michael Glibert beneficially owns 0 ENvue Medical common shares. This corresponds to 0.0% of the company’s outstanding common stock as of June 22, 2026, meaning he no longer holds a reportable stake.

When did Christian Michael Glibert cease to be a more-than-5% ENvue Medical shareholder?

The filing states that on June 22, 2026, Christian Michael Glibert ceased to be the beneficial owner of more than 5.0% of ENvue Medical’s common stock. This change followed his sale of 210,000 shares in open market transactions that fully liquidated his position.

Does Christian Michael Glibert have any agreements related to ENvue Medical securities?

The amendment states there are no contracts, arrangements, understandings, or relationships between Christian Michael Glibert and any other person regarding ENvue Medical securities. Information in Items 4 and 5 is incorporated, confirming only the reported sales and ownership change.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 2)

ENvue Medical, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

29416M103

(CUSIP Number)

Christian Glibert
4001 GREEN HERON SPRING DR,
Carpinteria, CA, 93013
7405077228

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

06/22/2026

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

schemaVersion:

SCHEDULE 13D

CUSIP Number(s): 29416M103

1

Name of reporting person

Glibert Christian Michael

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

0.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0.0 %

14

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Common Stock
(b)	Name of Issuer: ENvue Medical, Inc.
(c)	Address of Issuer's Principal Executive Offices: 969 PRUITT AVE,, TYLER, TEXAS , 77569.
Item 2.	Identity and Background
(a)	This Amendment No. 2 is being filed by Christian Michael Glibert. The citizenship, principal occupation, and background of the Reporting Person have not changed since the filing of the initial Schedule 13D
Item 3.	Source and Amount of Funds or Other Consideration
	Item 3 is hereby amended and supplemented by adding the following: Not applicable. The transactions reported herein involve the disposition (sale) of securities of the Issuer, and no funds were expended by the Reporting Person
Item 4.	Purpose of Transaction
	Item 4 is hereby amended and supplemented by adding the following: This Amendment No. 2 is being filed to report that the Reporting Person has fully liquidated his investment position in the Issuer. On June 22, 2026, the Reporting Person disposed of all remaining shares of Common Stock of the Issuer held by him. Except as a result of the transactions described in Item 5, the Reporting Person has no current plans or proposals that relate to or would result in any of the actions specified in clauses (a) through (j) of Item 4 of Schedule 13D.
Item 5.	Interest in Securities of the Issuer
(a)	Item 5 is hereby amended and restated in its entirety as follows: (a) As of June 22, 2026, the Reporting Person beneficially owns 0 shares of Common Stock of the Issuer, representing 0.0% of the outstanding shares.
(b)	(b) The Reporting Person has sole voting power and sole dispositive power over 0 shares of Common Stock, and shared voting power and shared dispositive power over 0 shares of Common Stock.
(c)	(c) On June 22, 2026, the Reporting Person disposed of an aggregate of 210,000 shares of Common Stock in open market transactions at a weighted average price of $0.6880 per share. The shares were sold in multiple tranches at prices ranging from $0.6756 to $0.7220.
(d)	(d) Not applicable.
(e)	(e) On June 22, 2026, the Reporting Person ceased to be the beneficial owner of more than 5.0% of the Common Stock of the Issuer.
Item 6.	Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer
	Item 6 is hereby amended and supplemented by adding the following: The information set forth in Item 4 and Item 5 of this Amendment No. 2 is incorporated herein by reference. There are no contract arrangements, understandings, or relationships between the Reporting Person and any other person with respect to the securities of the Issuer.
Item 7.	Material to be Filed as Exhibits.
	None

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Glibert Christian Michael

Signature:	/s/ Christian Michael Glibert
Name/Title:	Christian Michael Glibert
Date:	06/22/2026